title: No evidence for increased prostate cancer risk among calcium channel blockers user.
authors: Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China.
authors: Yu
authors: Y
authors: Fan
authors: Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China.
authors: Yongjing
authors: Y
authors: Zhou
authors: Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China.
authors: Dandan
authors: D
authors: Gong
authors: Institute of Molecular Biology & Translational Medicine, The Affiliated People's Hospital, Jiangsu University, Zhenjiang, Jiangsu 212002, PR China. Electronic address: zouchenzhj@163.com.
authors: Chen
authors: C
authors: Zou
mesh_terms: D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D014943:Global Health; D006801:Humans; D015994:Incidence; D008297:Male; D015201:Meta-Analysis as Topic; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology; D011634:Public Health; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors
chemical_list: D002121:Calcium Channel Blockers
keywords: Calcium channel blockers; Meta-analysis; Prostate cancer